Home News Syapse Partners with Infor to Revolutionize Cancer Care
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Syapse Partners with Infor to Revolutionize Cancer Care

Infor Cloverleaf to deliver integrated and modern applications in the cloud

by wrich

NEW YORK – Feb. 24, 2022 – Infor, the industry cloud company, today announced the success that Syapse has seen with cloud-based Infor CloudSuite Cloverleaf, built on Amazon Web Services® (AWS), to more easily refine and extract essential information from disparate data sources, prioritize scalability and boost privacy and security. Syapse, a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care, chose Infor to take data from a wide variety of community health systems and provide insights that can positively influence ongoing patient care. As a data-driven healthcare organization, Syapse relies on compiling real-world evidence that illustrates the entire course of cancer care for patients. Syapse selected Infor to help collect, analyze, and leverage massive amounts of pertinent data that can have significant consequences for patients and healthcare providers.  

“Syapse’s mission is to support precision cancer care worldwide, and we are constantly looking for partners that can support our industry-leading data ingestion and analytics capabilities to drive real impact for patients with cancer,” said Vinod Subramanian, Syapse chief data and product development officer. “Infor’s credibility and proven performance make it the right partner for us to help create an interface engine that is trusted by hospitals, licensed customers, and everyone in the market.” 

By partnering with Infor, Syapse aimed to elevate its three primary operational priorities—compiling and processing data intelligence, using analytics to draw insights, and applying them to patient care. With Infor Cloverleaf, Syapse has utilized powerful tools to aggregate numerous sources of data streams in a structured, efficient manner while providing easy and secure access to it as needed and adhering to strict regulatory compliance. 

Since its implementation, Infor Cloverleaf has provided Syapse’s certified team of tumor registrars with access to patient records that are used to enhance and validate data, creating a curated patient database that’s far more robust in usability and applicability. In addition, the organization can transform the massive information sprawl in raw data feeds into relevant research questions and answers, work across geographic boundaries and varying data management regulations, source data in a scalable and maintainable way — especially with multiple layers of security and privacy restrictions — and mitigate the risk to corporate and sourced data. Since go-live, data processing capabilities have accelerated from 18,000 records/hour and a 2-year backload to 3.2 million records/hour with a 5-day processing time. This means questions from trusted data get answered even faster. 

“In healthcare, once we realize that not all data is created equal, we can improve the way it is collected, consumed, and analyzed, and then we can improve the lives of our communities,” said Matt Breslin, Infor executive vice president. “Partnering with a leading organization like Syapse is exciting for us because, together, we can directly impact treatment and lead the industry in providing real-world evidence that empowers better care.” 

For more information, visit https://www.infor.com/products/cloverleaf


You may also like